-
公开(公告)号：EP3972580A1
公开(公告)日：2022-03-30
申请号：EP20725609.0
申请日：2020-05-21
发明人： BARCHIELLI, Marco , GOMENI, Roberto
IPC分类号： A61K31/198 , A61P3/12 , A61P13/12
-
公开(公告)号：EP3525761A1
公开(公告)日：2019-08-21
申请号：EP17784260.6
申请日：2017-10-10
IPC分类号： A61K9/16 , A61K31/145 , A61K31/7024
-
公开(公告)号：EP3308773A1
公开(公告)日：2018-04-18
申请号：EP16193180.3
申请日：2016-10-11
IPC分类号： A61K9/16 , A61K31/145 , A61K31/7024
CPC分类号： A61K9/1617 , A61K9/0095 , A61K9/167 , A61K9/5084 , A61K31/145 , A61K31/7024 , A61K2300/00
摘要： Oral cysteamine formulation consisting of dry layered lipid matrix microparticles useful for treating cystinosis and neurodegenerative disorders are described.
摘要翻译： 描述了用于治疗胱氨酸血症和神经变性疾病的由干燥的分层脂质基质微粒组成的口服半胱胺制剂。
-
公开(公告)号：EP3796888A1
公开(公告)日：2021-03-31
申请号：EP19724505.3
申请日：2019-05-17
IPC分类号： A61K9/00 , A61K45/06 , A61K31/145 , A61K9/16 , A61P11/12
-
公开(公告)号：EP3544584A1
公开(公告)日：2019-10-02
申请号：EP17800854.6
申请日：2017-11-20
发明人： BERLATI, Fabio , MENEGON, Sergio , FARINA, Pierluigi , PROVVEDINI, Diego , BARCHIELLI, Marco , MATTEI, Alberto
摘要： The present invention relates to a pharmaceutical formulation suitable for parenteral administration containing carglumic acid and a buffering agent having a pK a from 5.5 to 9.0 at 25°C; according to an embodiment, the buffering agent may have a pK a from 7.5 to 8.5, preferably a pK a of about 8.07, such as trometamol. The formulation may also contain at least one bulking agent, such as mannitol. The invention also includes a method for manufacturing a lyophilised sterile formulation by freeze-drying a water solution containing carglumic acid, a buffering agent having a pK a from 5.5 to 9.0 at 25°C, preferably from 7.5 to 8.5, and optionally a bulking agent to obtain a freeze-dried powder.
-
公开(公告)号：EP3429565A1
公开(公告)日：2019-01-23
申请号：EP17712937.6
申请日：2017-03-14
IPC分类号： A61K9/50 , A61K31/145
-
公开(公告)号：EP2874610B1
公开(公告)日：2018-08-29
申请号：EP13739675.0
申请日：2013-07-18
IPC分类号： A61K9/00 , A61K9/20 , A61K9/24 , A61K45/06 , A61K31/192 , A61K31/195 , A61K9/46
CPC分类号： A61K9/0065 , A61K9/0007 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2054 , A61K9/2059 , A61K9/209 , A61K9/2095 , A61K31/192 , A61K31/195 , A61K45/06 , A61K2300/00
摘要： An oral trilayered formulation with multi-kinetic release in different sites of the gastro-intestinal tract, particularly suitable for the administration of combinations of active ingredients is described.
-
公开(公告)号：EP2874610A1
公开(公告)日：2015-05-27
申请号：EP13739675.0
申请日：2013-07-18
CPC分类号： A61K9/0065 , A61K9/0007 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2054 , A61K9/2059 , A61K9/209 , A61K9/2095 , A61K31/192 , A61K31/195 , A61K45/06 , A61K2300/00
摘要： An oral trilayered formulation with multi-kinetic release in different sites of the gastro-intestinal tract, particularly suitable for the administration of combinations of active ingredients is described.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.014 秒)
